Randall Bateman, MD

Read about Randall Bateman, MD

Washington University School of Medicine

2004 Corporate Round Table Clinical Research Training Fellowship In Vivi Metabolism of AB in Alzheimer’s Disease

Target brain disease(s): Alzheimer’s Disease

Project goal: Investigate different biomarkers, or laboratory tests, to determine ways to predict who will be affected by Alzheimer’s disease before they have symptoms of it.

Project description: Alzheimer’s disease can affect the identity of the individuals fighting the disease and be emotionally and financially devastating to their loved ones. There are inherited forms of Alzheimer’s disease, a progressive, debilitating disorder, that can be passed from parents to children. Dr. Bateman’s research showed that laboratory signs of the disorder could be found 5 to 15 years before the signs of the disease are detected. Being able to predict who will get Alzheimer’s disease will help us understand how to make the disease less severe or even prevent “at risk” individuals from getting it.

Link to related study: Bateman RJ, et al. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. N Engl J Med 2012; 367:795-804

Funding: Received $130,000 in research funds.